Trump Media (NASDAQ: DJT) Soars 24%: Opens at $71.
Post# of 25327
https://www.marketscreener.com/quote/stock/DI...-46310205/
The former United States President Donald J. Trump is making headlines due to the upcoming presidential elections as a candidate. However, he created buzz in the financial world after Trump Media & Technology Group Corp. (NASDAQ: DJT) went public yesterday. This company is the parent of Truth Social, his personal social media platform.
Trump Media & Technology Group Corp. (NASDAQ: DJT) commenced trading on Tuesday March 26, 2024. On its debut day of trading, the stock soared, achieving gains of up to 16%. The company went public through a merger with Digital World Acquisition Corp., (NASDAQ: DWAC) a special-purpose acquisition company (SPAC). The stock experienced significant pre-market trading activity today, with a substantial gap up of $71.93, marking a 24% increase from yesterday's closing price.
Shareholders approved the deal last week. Digital World Acquisition has been publicly listed since 2021. Trump Media & Technology Group's stock closed at $57.99 per share yesterday, giving it a market capitalization of approximately $8 billion. Donald Trump launched Truth Social after being banned from platforms like Twitter and Facebook post-Capitol riots on January 6, 2021. While he's back on those platforms, he remains active on Truth Social.
The former United States President Donald J. Trump owns approximately 60% of Truth Social, valued at $5 billion. Media incurred losses of $49 million in the first nine months, with revenues at $3.4 million during the same period. In any event this is an intriguing stock to monitor as it is expected to continue rising in the near term without showing signs of leveling off.
Dyadic International Inc. (NASDAQ: DYAI): CEO Mark Emalfarb highlights C1 Platform's Game-Changing Impact, Drawing Parallels to Tesla, Inc. (NYSE: TSLA)'s Automotive Industry Transformation on The Street Reports Podcast. Explore the Insights! Also, on March 26, 2024, Dyadic's Groundbreaking Manuscript, 'Filamentous Fungus-Produced Human Monoclonal Antibody Offers SARS-CoV-2 Protection in Hamster and Nonhuman Primate Models,' Published in Nature Communications, a Prestigious Global Journal Renowned for Cutting-Edge Science and Technology Journal. Dive into the Journal Review Now!
Intelligent Bio Solutions Inc. (Nasdaq: INBS) a medical technology company delivering intelligent, rapid, non-invasive testing solutions, announced they are scheduled to present at the LD Micro Invitational XIV Investor Conference to be held on April 8-9, 2024, in New York City. On March 12, 2024, Intelligent Bio Solutions Inc. announced that it had closed the private placement to generate gross proceeds to the tune of $10.1 million from the placement before the deduction of placement fees and other costs.
Catheter Precision Inc. (NYSE American: VTAK): Leading U.S. Medical Device Firm Specializing in Electrophysiology Products Featured in "MedTech Outlook". On March 14, 2024, Catheter Precision Inc. Debuts VIVO System in Pioneering Procedures at Hamad Medical Corporation Heart Hospital, Qatar's Premier Healthcare Institution. Explore VTAK's Innovations!